Key points are not available for this paper at this time.
Design
Editorial
Clinical scores such as GRACE, TIMI, and CHA2DS2-VASc are valuable tools for risk stratification in acute coronary syndrome and atrial fibrillation, with potential utility in other clinical scenarios.
Diagnostic labels can be quite opaque regarding prognosis.Under the umbrella of the same medical term, for example non-ST-elevation acute coronary syndrome (NSTE-ACS), we bring together patients with a similar pathophysiological condition, but dramatically different probabilities of dying.These prognostic differences influence the aggressiveness of treatments proposed for each patient.Medical scores are helpful tools to predict outcomes and to stratify patients into different levels of risk. 1 In modern cardiovascular medicine, the GRACE, TIMI and CHA 2 DS 2 VASc scores are used to predict clinical outcome in patients with acute coronary syndrome (ACS) and atrial fibrillation. 2After they gained wide acceptability in clinical practice, the potential utility of these scores for other clinical purposes has been further explored.For example, CHA 2 DS 2 VASc is able to predict postoperative atrial fibrillation after cardiac surgery, as well as death or heart failure hospitalization in patients who have undergone cardiac resynchronization therapy. 3,4
No takes yet. Share an insight, caveat, or question.
Luz et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: